<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16526">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02891746</url>
  </required_header>
  <id_info>
    <org_study_id>Mat-Neo-Micro-HMO-CTIL</org_study_id>
    <nct_id>NCT02891746</nct_id>
  </id_info>
  <brief_title>Maternal and Neonatal Microbiome</brief_title>
  <official_title>The Neonatal Microbiome and Its Influence on the Post-partum Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bar-Ilan University, Israel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to characterize and monitor the microbiome of premature infants born
      in the investigators facility until discharge from the NICU. The investigators will also
      examine the relationship between mode of delivery and the microbiome of the infant, while
      exploring various possible factors that may affect it. In addition, the investigators will
      compare the microbiome of premature infants to the microbiome of term babies born at the
      same time in the same facility.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Definition the flora comprising the microbiome of premature and term babies</measure>
    <time_frame>birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in the microbiome of the infants born vaginally and via caesarian section</measure>
    <time_frame>birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the flora that constitutes the microbiome of premature babies</measure>
    <time_frame>birth until adjusted age of 40 weeks gestation</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Microbiota</condition>
  <arm_group>
    <arm_group_label>Premature infants</arm_group_label>
    <description>premature infants ≤ 34 weeks of gestation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term infants</arm_group_label>
    <description>neonates ≥ 37 weeks gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non invasive sampling</intervention_name>
    <arm_group_label>Premature infants</arm_group_label>
    <arm_group_label>Term infants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 premature infants ≤ 34 weeks of gestation admitted to the Neonatal Intensive Care Unit
        and their mothers.

        The control group :

        100 neonates ≥ 37 weeks gestation of which 50 were delivered vaginally and 50 by Caesarean
        section and their mothers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premature infants ≤ 34 weeks of gestation admitted to the Neonatal Intensive Care
             Unit at Hadassah University Hospital, Mount Scopus and their mothers.

        The control group:

          -  Neonates ≥ 37 weeks gestation of which 50 were delivered vaginally and 50 by
             Caesarean section at Hadassah University Hospital, Mount Scopus and their mothers.

        Exclusion Criteria:

          -  Neonates with congenital anomalies or metabolic conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Drorith Hochner-Celnikier, MD</last_name>
    <phone>00 972 2 5844410</phone>
    <email>hochner@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization, Jerusalem, Israel</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>0097226777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Drorith Cenikier-Hochner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>September 1, 2016</lastchanged_date>
  <firstreceived_date>May 31, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
